Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds. Its structure allows for selective functionalization in the development of nitrogen-containing heterocyclic compounds, commonly found in bioactive molecules and drug candidates. Frequently employed in the preparation of kinase inhibitors and other therapeutic agents targeting central nervous system disorders and oncology. The presence of both bromo and boronic acid groups enables sequential coupling reactions, offering versatility in multi-step synthetic routes. Also applied in agrochemical research for designing novel active ingredients with improved efficacy and selectivity.